Related Experiment Video
Updated: Jul 8, 2026
08:13
In Vivo Confocal Microscopy in the Diagnosis and Management of Dry Eye: A Focus on Imaging Protocols and Interpretation
Published on: November 11, 2025
Inflammatory cystoid macular edema.
1Department of Ophthalmology, University Medical Center, Utrecht, The Netherlands. a.rothova@umcutrecht.nl
Current Opinion in Ophthalmology
|December 29, 2007
Summary
Inflammatory cystoid macular edema, a common cause of vision loss in uveitis and HIV, shows temporary improvement with current treatments. New research on aqueous constituents and OCT imaging may lead to better strategies.
Area of Science:
- Ophthalmology
- Immunology
- Retinal Diseases
Background:
- Cystoid macular edema (CME) is a significant cause of vision loss, particularly in uveitis patients.
- It is increasingly recognized in HIV-infected individuals with immune recovery uveitis.
- Elevated pro-inflammatory cytokines and vascular endothelial growth factor (VEGF) are implicated in CME pathogenesis.
Purpose of the Study:
- To provide an updated understanding of inflammatory cystoid macular edema (CME).
- To review current management strategies for inflammatory CME.
- To highlight recent advances and future directions in CME treatment.
Main Methods:
- Review of current literature on inflammatory cystoid macular edema.
- Analysis of findings related to uveitis and HIV-associated CME.
- Evaluation of treatment outcomes and emerging therapeutic approaches.
Main Results:
- CME is common in chronic uveitis and immune recovery uveitis, often preceded by subclinical OCT changes.
- Anti-inflammatory and anti-VEGF treatments offer temporary benefits for CME.
- Clear guidelines for subclinical CME in uveitis are lacking; vitrectomy's role is under investigation.
Conclusions:
- Current treatments for inflammatory CME provide temporary relief.
- Advances in intravitreal drug delivery systems are improving CME management.
- Future research focusing on aqueous humor analysis and advanced OCT imaging promises enhanced CME treatment strategies.
Related Concept Videos
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:19Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...